Injectable products include Ozempic, Wegovy, Trulicity, Mounjaro, Zepbound, Victoza, Saxenda, and exenatide formulations
Long-term human studies are still limited, which is why clinician oversight and ongoing monitoring are important
The search terms are glucagon-like peptide-1 receptor agonist (including exenatide, liraglutide, albiglutide, lixisenatide, semaglutide, dulaglutide, taspoglutide), sodium glucose cotransporter 2 inhibitor (including canagliflozin, empagliflozin, dapagliflozin, ipragliflozin, luseogliflozin, tofogliflozin, remogliflozin, sergliflozin, sotagliflozin, ertugliflozin) and type 2 diabetes mellitus
The ORs for mortality in patients at high and low cardiovascular risk were 0.50 (95% Cl 0.310.83) and 0.58 (95% Cl 0.231.48), respectively [56]
Age, current medications, medical history, and even lifestyle factors can change how a treatment works